We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
76 hedge funds and large institutions have $664M invested in Rocket Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
162% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 13
36% more funds holding
Funds holding: 56 → 76 (+20)
36% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 14
19% more capital invested
Capital invested by funds: $558M → $664M (+$106M)
7.6% more ownership
Funds ownership: 78.53% → 86.13% (+7.6%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
76
Holders Change
+20
Holders Change %
+35.71%
% of All Funds
1.74%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
34
Increased
19
Reduced
14
Closed
13
Calls
$672K
Puts
–
Net Calls
+$672K
Net Calls Change
+$70K
Top Buyers
| 1 |
BlackRock
New York
|
+$23.1M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$9.52M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$7.75M |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.81M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$6.74M |
Top Sellers
| 1 |
GTC
Ghost Tree Capital
New York
|
-$9.46M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$6.56M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$5.07M |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$4.69M |
| 5 |
Goldman Sachs
New York
|
-$2.52M |
